Literature DB >> 26815962

Traditional weight-based vancomycin dosing is inadequate in critically ill trauma patients.

D D Yeh1, M E Kutcher2, K Lunghi3.   

Abstract

PURPOSE: Our aim was to evaluate our institution's compliance with weight-based vancomycin dosing recommendations for pneumonia in critically ill injured patients and to assess the success rate in achieving therapeutic serum vancomycin levels. Additionally, we sought to assess the incidence of vancomycin-induced nephrotoxicity.
METHODS: All injured intensive care unit (ICU) patients receiving intravenous vancomycin between May 1, 2004 and July 31, 2010 were identified through our trauma database and pharmacy records. The initial weight-based dose was calculated and compared with vancomycin trough levels.
RESULTS: Thirty patients were identified who satisfied the inclusion/exclusion criteria. Only 12 patients (40%) received adequate weight-based dosing (weight-based, 30 mg/kg/day). Weight-based patients weighed significantly less than non-weight-based patients (62.7 vs. 84.2 kg, p = 0.0008). Weight-based patients were more likely to achieve therapeutic trough levels than non-weight-based patients (58 vs. 33%, p = 0.176). Of patients who achieved therapeutic trough levels, more weight-based patients achieved it at first trough than non-weight-based patients (33 vs. 5.6%, p = 0.046).
CONCLUSIONS: When prescribing commonly used dosing regimens, appropriate weight-based administration of vancomycin occurred in only approximately one-third of patients. Those patients who did receive weight-based vancomycin dosing were more likely to achieve therapeutic levels, both initially (33 vs. 5.6%) and overall (58 vs. 33%).

Entities:  

Keywords:  Antibiotics; ICU; Pneumonia; Trauma; Vancomycin

Year:  2011        PMID: 26815962     DOI: 10.1007/s00068-011-0164-8

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  30 in total

1.  Necessity of a loading dose when using vancomycin in critically ill patients.

Authors:  J T Wang; C T Fang; Y C Chen; S C Chang
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

2.  Pulmonary disposition of vancomycin in critically ill patients.

Authors:  H Georges; O Leroy; S Alfandari; B Guery; M Roussel-Delvallez; C Dhennain; G Beaucaire
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

3.  Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection.

Authors:  A Di Filippo; A R De Gaudio; A Novelli; E Paternostro; C Pelagatti; P Livi; G P Novelli
Journal:  Chemotherapy       Date:  1998 Jan-Feb       Impact factor: 2.544

Review 4.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Authors:  K Hiramatsu
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

5.  Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.

Authors:  Doris Hutschala; Christian Kinstner; Keso Skhirdladze; Florian Thalhammer; Markus Müller; Edda Tschernko
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

6.  Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections.

Authors:  Karine Berthoin; Els Ampe; Paul M Tulkens; Stephane Carryn
Journal:  Int J Antimicrob Agents       Date:  2009-09-26       Impact factor: 5.283

7.  Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.

Authors:  Baudouin Byl; Frédérique Jacobs; Pierre Wallemacq; Camelia Rossi; Philippe de Francquen; Matteo Cappello; Teresinha Leal; Jean-Pierre Thys
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

8.  Vancomycin dosing for pneumonia in critically ill trauma patients.

Authors:  Asad E Patanwala; Christopher J Norris; David E Nix; Brian J Kopp; Brian L Erstad
Journal:  J Trauma       Date:  2009-10

9.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

Review 10.  Simplified dosing and monitoring of vancomycin for the burn care clinician.

Authors:  T L Rice
Journal:  Burns       Date:  1992-10       Impact factor: 2.744

View more
  1 in total

1.  Currently used dosage regimens of vancomycin fail to achieve therapeutic levels in approximately 40% of intensive care unit patients.

Authors:  Vitor Yuzo Obara; Carolina Petrus Zacas; Claudia Maria Dantas de Maio Carrilho; Vinicius Daher Alvares Delfino
Journal:  Rev Bras Ter Intensiva       Date:  2016 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.